Faculty Opinions recommendation of Clinical course of children and adolescents with bipolar spectrum disorders.

Author(s):  
Luise Poustka
2006 ◽  
Vol 63 (2) ◽  
pp. 175 ◽  
Author(s):  
Boris Birmaher ◽  
David Axelson ◽  
Michael Strober ◽  
Mary Kay Gill ◽  
Sylvia Valeri ◽  
...  

2009 ◽  
Vol 11 (1) ◽  
pp. 52-62 ◽  
Author(s):  
Boris Birmaher ◽  
David Axelson ◽  
Michael Strober ◽  
Mary Kay Gill ◽  
Mei Yang ◽  
...  

2006 ◽  
Vol 63 (10) ◽  
pp. 1139 ◽  
Author(s):  
David Axelson ◽  
Boris Birmaher ◽  
Michael Strober ◽  
Mary Kay Gill ◽  
Sylvia Valeri ◽  
...  

2010 ◽  
Vol 71 (10) ◽  
pp. 1344-1350 ◽  
Author(s):  
Regina Sala ◽  
David A. Axelson ◽  
Josefina Castro-Fornieles ◽  
Tina R. Goldstein ◽  
Wonho Ha ◽  
...  

CNS Spectrums ◽  
2015 ◽  
Vol 20 (4) ◽  
pp. 359-368 ◽  
Author(s):  
Manpreet K. Singh ◽  
Amy S. Garrett ◽  
Kiki D. Chang

Mood disorders are increasing in childhood, and often require multimodal and comprehensive treatment plans to address a complex array of symptoms and associated morbidities. Pharmacotherapy, in combination with psychotherapeutic interventions, is essential for treatment and stabilization. Current evidence supports the use of a number of interventions in children and adolescents diagnosed with DSM-5 mood spectrum disorders, which are associated with impairments in prefrontal–striatal–limbic networks, which are key for emotional functioning and regulation. Yet, little is known about the neurobiological effects of interventions on the developing brain. This chapter provides a synopsis of the literature demonstrating the neural effects of psychotropic medications and psychotherapy in youth with depressive or bipolar spectrum disorders. Additional longitudinal and biological studies are warranted to characterize the effects of these interventions on all phases and stages of mood illness development in children and adolescents.


Sign in / Sign up

Export Citation Format

Share Document